Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
AlphaTON Capital Corp. (ATON)
Company Research
Source: GlobeNewswire
Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) (“AlphaTON”) and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (“Cyncado”), today announced a poster presentation at the Society for Immunotherapy of Cancer Annual Meeting, taking place November 5 to 9, 2025, in National Harbor, Maryland. The poster reports preclinical findings from work conducted by investigators at the National Cancer Institute (NCI) at NCI laboratories. In these studies, NCI researchers evaluated combinations of selective adenosine A2B antagonism (TT-4) and A2A antagonism (TT-10) with antigen-specific cancer vaccines. Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that strategies optimized to inhibit both adenosine A2B and A2A receptor mediated immune suppression can synergize with therapeuti
Show less
Read more
Impact Snapshot
Event Time:
ATON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATON alerts
High impacting AlphaTON Capital Corp. news events
Weekly update
A roundup of the hottest topics
ATON
News
- AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA EventGlobeNewswire
- AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration StatementGlobeNewswire
- AlphaTON Capital Successfully Deploys First Fleet of Nvidia B200 GPUs to Telegram's Cocoon AI Network, Powering Privacy-First AI for One Billion UsersGlobeNewswire
- AI Chips Update - AlphaTON Invests $82.5M In Nvidia-Powered AI Expansion [Yahoo! Finance]Yahoo! Finance
- AlphaTON Commits $82.5 Million to Telegram's Cocoon AI, Including Nvidia GPU Cluster [Yahoo! Finance]Yahoo! Finance
ATON
Sec Filings
- 12/3/25 - Form F-3
- 11/26/25 - Form 6-K
- 11/26/25 - Form 424B5
- ATON's page on the SEC website